Skip to main content
OpenTrials

Clinical trial condition

Rectal Diseases

Explore clinical trials studying Rectal Diseases. Study availability and eligibility vary by location and protocol.

5,954 public trials 1,253 recruiting studies
Refine in advanced search Browse all conditions

Rectal Diseases trial results

Recruiting

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

NCT07284849

Conditions
CRC (Colorectal Cancer), Colonic Diseases, Colonic Neoplasms, +10 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Roche Tissue Diagnostics, Companion Diagnostics Tucson, Arizona, United States
  • Memorial Care Orange Coast Medical Center Fountain Valley, California, United States
  • Providence Medical Foundation Fullerton, California, United States
View all 255 locations
View Trial Details
Recruiting

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

NCT07318805

Conditions
Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +19 more
Locations
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • START Midwest, LLC Grand Rapids, Michigan, United States
  • Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy Long Island City, New York, United States
  • Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street). New York, United States
View all 13 locations
View Trial Details
Recruiting

DESTINY-PANTUMOUR04

NCT07124000

Conditions
Adenocarcinoma, Adenocarcinoma (NOS), Adnexal Diseases, +116 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Bullhead City, Arizona, United States
  • Research Site Casa Grande, Arizona, United States
  • Research Site San Diego, California, United States
View all 18 locations
View Trial Details
Recruiting

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

NCT05253651

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
Locations
  • Palo Verde Hematology Oncology Glendale, Arizona, United States
  • Mayo Clinic Building - Phoenix Phoenix, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
View all 366 locations
View Trial Details
Recruiting

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

NCT06131840

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +21 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • IP Address: City of Hope Investigational Drug Services(IDS) Duarte, California, United States
View all 48 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

NCT07221357

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Local Institution - 0428 Tucson, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center Orange, California, United States
View all 281 locations
View Trial Details

Related conditions